| 1 |
34599645 | No significant influence of OCT1 genotypes on the pharmacokinetics of morphine in adult surgical patients. | 2022 Jan |
2 |
| 2 |
33847389 | Pharmacogenomics and Morphine. | 2021 Sep |
1 |
| 3 |
33967805 | Transport of Drugs and Endogenous Compounds Mediated by Human OCT1: Studies in Single- and Double-Transfected Cell Models. | 2021 |
3 |
| 4 |
31630405 | Quantitative Proteomics and Mechanistic Modeling of Transporter-Mediated Disposition in Nonalcoholic Fatty Liver Disease. | 2020 May |
1 |
| 5 |
32090339 | Influence of MRP3 Genetics and Hepatic Expression Ontogeny for Morphine Disposition in Neonatal and Pediatric Patients. | 2020 Aug |
1 |
| 6 |
30300922 | Influence of OCT1 Ontogeny and Genetic Variation on Morphine Disposition in Critically Ill Neonates: Lessons From PBPK Modeling and Clinical Study. | 2019 Mar |
2 |
| 7 |
31597043 | Opioids as Substrates and Inhibitors of the Genetically Highly Variable Organic Cation Transporter OCT1. | 2019 Nov 14 |
1 |
| 8 |
29920988 | PBPK Model of Morphine Incorporating Developmental Changes in Hepatic OCT1 and UGT2B7 Proteins to Explain the Variability in Clearances in Neonates and Small Infants. | 2018 Jul |
2 |
| 9 |
29994939 | Genetics and genomics in postoperative pain and analgesia. | 2018 Oct |
2 |
| 10 |
30361780 | Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2). | 2018 Oct 25 |
8 |
| 11 |
30544975 | Impact of Promoter Polymorphisms on the Transcriptional Regulation of the Organic Cation Transporter OCT1 (SLC22A1). | 2018 Dec 11 |
3 |
| 12 |
27935268 | Characterization of Contributing Factors to Variability in Morphine Clearance Through PBPK Modeling Implemented With OCT1 Transporter. | 2017 Feb |
4 |
| 13 |
28063968 | Lack of genetic association between OCT1, ABCB1, and UGT2B7 variants and morphine pharmacokinetics. | 2017 Mar 1 |
1 |
| 14 |
28470102 | OCT1 genetic variants are associated with postoperative morphine-related adverse effects in children. | 2017 May |
7 |
| 15 |
29061087 | OCT1 pharmacogenetics in pain management: is a clinical application within reach? | 2017 Nov |
1 |
| 16 |
29236753 | Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine. | 2017 |
3 |
| 17 |
25155932 | ABCC3 and OCT1 genotypes influence pharmacokinetics of morphine in children. | 2014 Jul |
4 |
| 18 |
23835420 | Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration. | 2013 Sep 1 |
10 |
| 19 |
23859569 | OCT1 genetic variants influence the pharmacokinetics of morphine in children. | 2013 Jul |
3 |
| 20 |
23922447 | Hepatocyte nuclear factor 1 regulates the expression of the organic cation transporter 1 via binding to an evolutionary conserved region in intron 1 of the OCT1 gene. | 2013 Oct |
1 |